Sickle cell disease affects 100,000 people in the United States and far more internationally. One of the most dangerous manifestations of the disease is acute chest syndrome, which involves a vicious cycle of erythrocyte sickling and respiratory failure. Acute chest syndrome can be a presenting feature upon hospital admission, it can arise as a complication of a vasoocclusive pain crisis, or it can occur as a complication from a surgical procedure. As such, we should always be on the lookout for this entity whenever caring for patients with sickle cell disease. COVID-19 is a particular threat that can cause acute chest syndrome, which may require especially aggressive management (e.g. early exchange transfusion).
-
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
- Pulmcrit wee: The cutoff razor - April 15, 2024
- PulmCrit Blogitorial – Use of ECGs for management of (sub)massive PE - March 24, 2024
- PulmCrit Wee: Propofol induced eyelid opening apraxia – the struggle is real - March 20, 2024
Dear Josh,
thanks a lot for all the great posts. You might have already noticed, but the units for the hemoglobin are wrong in the first part of the text (mg/dl instead of g/dl).
Best wishes,
Leo
Your thoughts on TPA for acute chest syndrome I had a physician recently order this vs exchange transfusion
[…] https://emcrit.org/pulmcrit/sickle-chest/ […]